Free tool
Dividend paying stocks
We cover 100 companies that currently pay a dividend. The median market value in the group is $1.14B. Across the group, the median move over the past trading day is +0.44%. 64% of the 99 with a 200-day average trade above it. Price change over the past year runs from −30.2% to +59.0% across the middle 80 percent of the group, with a median of +1.1%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
100 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | $7.26B | Mid cap | +5.09% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.84B | Small cap | +53.42% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% |
| NOLA-B.ST | Nolato AB (publ) | $1.50B | Small cap | −7.00% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| F9L.F | Joincare Pharmaceutical Group Industry Co.,Ltd. | $1.39B | Small cap | −48.41% |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% |
| SPH.WA | Sopharma AD | $1.13B | Small cap | −38.71% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% |
| NEU.WA | NEUCA S.A. | $946.21M | Small cap | +15.02% |
| PHN.MI | Pharmanutra S.p.A. | $921.01M | Small cap | +70.46% |
| SYNSAM.ST | Synsam AB (publ) | $873.75M | Small cap | +5.66% |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| LBIRD.PA | Lumibird SA | $658.60M | Small cap | +57.43% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | $564.79M | Small cap | −29.98% |
| BOI.PA | Boiron SA | $523.06M | Small cap | +21.99% |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| LNA.PA | LNA Santé SA | $405.74M | Small cap | +11.88% |
| M12.DE | M1 Kliniken AG | $401.97M | Small cap | +37.84% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| IDHC.L | Integrated Diagnostics Holdings plc | $298.80M | Small cap | +16.89% |
| PIHLIS.HE | Pihlajalinna Oyj | $283.18M | Small cap | −28.38% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| ORIOLA.HE | Oriola Oyj | $195.27M | Small cap | −21.98% |
| NYKD.OL | Nykode Therapeutics AS | $160.76M | Small cap | +204.86% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| CRAD-B.ST | C-Rad AB (publ) | $122.23M | Small cap | +6.49% |
| VISTN.OL | Vistin Pharma ASA | $91.60M | Micro cap | −15.42% |
| OMDA.OL | Omda AS | $81.21M | Micro cap | −23.98% |
| GENT.OL | Gentian Diagnostics ASA | $65.68M | Micro cap | −30.41% |
| AJ91.DE | DocCheck AG | $64.48M | Micro cap | −9.92% |
| HVO.L | hVIVO plc | $59.87M | Micro cap | −35.00% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| M3V.DE | MeVis Medical Solutions AG | $50.50M | Micro cap | −0.42% |
| ABLD.PA | ABL Diagnostics Société anonyme | $44.99M | Micro cap | −46.67% |
| X74.F | I.M.D. International Medical Devices S.p.A. | $20.60M | Micro cap | −22.17% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| PHR.WA | Pharmena S.A. | $9.45M | Micro cap | −8.72% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.